From Free Entry to Patent Protection: Welfare Implications for the Indian Pharmaceutical Industry

Antara Dutta
Additional contact information
Antara Dutta: Compass Lexecon, Washington, D.C.

The Review of Economics and Statistics, 2011, vol. 93, issue 1, 160-178

Abstract: There has been fierce debate over the imposition of stronger intellectual property rights laws for pharmaceutical products in developing countries. This paper uses data from the Indian pharmaceutical industry to develop a structural model of demand, supply and entry. The estimation yields demand and supply parameters that indicate significant heterogeneity among firms both within and across different therapeutic segments. The estimated parameters are used to simulate patent enforcement and price deregulation for 43 drugs, which predicts large losses for consumers and relatively small gains in profits for the global patent holders. © 2011 The President and Fellows of Harvard College and the Massachusetts Institute of Technology.

Date: 2011
References: Add references at CitEc
Citations: View citations in EconPapers (38)

Downloads: (external link)
http://www.mitpressjournals.org/doi/pdf/10.1162/REST_a_00056 link to full text (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tpr:restat:v:93:y:2011:i:1:p:160-178

Ordering information: This journal article can be ordered from
https://mitpressjour ... rnal/?issn=0034-6535

Access Statistics for this article

The Review of Economics and Statistics is currently edited by Pierre Azoulay, Olivier Coibion, Will Dobbie, Raymond Fisman, Benjamin R. Handel, Brian A. Jacob, Kareen Rozen, Xiaoxia Shi, Tavneet Suri and Yi Xu

More articles in The Review of Economics and Statistics from MIT Press
Bibliographic data for series maintained by The MIT Press ().